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Abstract 
Background: The non-fluoroscopy approach with the use of a three-dimensional (3D) 
navigation system is increasingly recognized as a future technology in the treatment of 
arrhythmias. However, there are a limited number of articles published concerning transseptal 
puncture without the use of fluoroscopy.  
Methods: Presented in this paper is  the first series of patients (n = 10) that have undergone 
transseptal puncture without the use of fluoroscopy under transesophageal echocardiography 
control using a radiofrequency transseptal needle and a 3D navigation system.  
Results: All patients were treated without complications. In six patients, re-pulmonary vein 
isolation was performed. In 5 cases, linear ablation of the left atrium for treatment of left atrial 
macro re-entry tachycardia was provided. In 2 patients, focal atrial tachycardia was treated, 1 
patient underwent cavo tricuspidal isthmus (CTI) ablation and one patient, re-CTI ablation. 
The ablation of complex fragmented atrial electrograms was done in 2 patients. In 1 case, 
right atrial macro re-entry tachycardia was treated.   
Conclusions: Transseptal puncture without using fluoroscopy is safe and effective when 
using a radiofrequency needle, a 3D navigation system and transesophageal 
echocardiography. 
Key words: non-fluoroscopic approach, transseptal puncture, radiofrequency needle, 
three-dimensional mapping system 
 
 
Introduction 
Interest in non-fluoroscopy radiofrequency (RF) ablation (RFA) for the treatment of 
supraventricular tachycardia (SVT) arising from the right atrium (RA) has increased greatly 
over the last decade [1]. A new generation of three-dimensional (3D)-navigation systems 
allow the operator to build a map of the right-sided chambers with no, or minimal use of 
fluoroscopy. Number of publications in accordance with the safety and efficacy of non-
fluoroscopy RFA of SVT have recently been published [2, 3]. Little is known about the safety 
and efficacy of transseptal puncture (TSP) using the non-fluoroscopy technique. As such, this 
paper presents a series of TSPs and RFA of the left atrium (LA) using a RF needle, 3D 
navigation system and transesophageal echocardiography (TEE), without the use of 
fluoroscopy. 
 
Methods 
Thirteen consecutive patients were enrolled in this study. Three patients were 
excluded because of persistent foramen ovale or interatrial septal (IAS) defect after the first 
RFA. Nevertheless, they were also successfully ablated using the no-fluoroscopy technique. 
In 10 patients (6 female) with a mean age of 70.6  6.5 years, an RF needle was used 
for TSP. All patients underwent initial ablation therapy for atrial fibrillation (AF). Nine 
patients had pulmonary vein isolation (PVI) using cryoballoon, one patient had  PVI using an 
RF catheter and 2 patients had re-PVI using an RF catheter after the first PVI procedure was 
conducted using a cryoballoon. Two patients had  paroxysmal form and 8 patients had a 
persistent form of AF. Typical atrial flutter was documented in 4 cases. Eight patients had 
arterial hypertension, 2 patients suffered from apoplexy, 1 patient had diabetes, and 1 patient 
had chronic obstructive pulmonary disease (COPD). In 2 patients, ischemic heart disease was 
diagnosed, one was treated with coronary artery bypass grafting and  the other with coronary 
stenting. None of the patients had implanted cardiac devices. 
All procedures were done under sedation and uninterrupted anticoagulation. 
Intravenous infusion of Propofol and Fentanyl injection was used. Intravenous heparin was 
administered during the procedure to maintain an activated clotting time (ACT) in excess of 
300 s. 
Vascular access was obtained from the right femoral vein. 4 F and 8 F short sheaths 
and one 8.5 F long sheath (SL1 with atraumatic tip, SWARTZ, Abbott, USA) was inserted 
(see details below). 
The 3D navigation system (Ensite Precision Cardiac Mapping System, Abbott, 
USA) was used in all cases. Initial anatomical mapping of right-sided heart structures was 
performed using a 4 F decapolar steerable diagnostic catheter (Inquiry, Abbott, USA), 
which then was placed in the coronary sinus (CS). For mapping of the LA and the pulmonary 
veins, a circular mapping catheter (Advisor™ FL, Sensor Enabled™, Abbott, USA) or a 
multipolar mapping catheter (Advisor™ HD Grid, Sensor Enabled™, Abbott, USA) was 
used. Mapping and ablation were performed with an irrigated ablation catheter (Flexability™, 
Abbott, USA). The TSP was performed with a RF-Needle (NRG Transseptal Needle, Baylis 
Medical Company Inc., Canada) in all cases. All TSPs were performed under TEE imaging 
using a compact cardiovascular ultrasound system (CX50, PHILIPS, Netherland) with a TEE 
array transducer (X7-2t, PHILIPS, Netherlands).  
 
The TSP with RF needle  
The technique was divided into three steps. 
1. Right-sided anatomical mapping. The anatomical mapping of right-sided 
structures using a steerable diagnostic catheter is safe and effective, and does not take a lot of 
time. First, mapping of the venous system and the inferior vena cava (IVC) was undertaken. 
Followed by mapping of the right atrium (RA) especially the IAS, superior vena cava (SVC) 
and the CS. Afterwards, a long transseptal sheath was inserted into the femoral vein over a 
long wire (10–20 cm) to ensure that the tip of the sheath was in the venous system. After the 
dilator and wire was withdrawn, the sheath was aspirated and flushed with saline and the 
ablation catheter was inserted. Once the RF catheter was in the venous system, its trajectory 
was tracked through the 3D anatomical course of the venous system which was established 
using a diagnostic catheter. Once the ablation catheter was placed in the SVC, the long sheath 
was slid carefully over it. It was inserted until an impedance difference occurred (once the tip 
of the sheath made contact with the catheter electrodes) and the catheter shape was moved out 
from the 3D anatomical map borders. This confirmed “housing” of the RF catheter in the 
sheath. Then the catheter was withdrawn and the sheath was aspirated and flushed again with 
saline (Fig. 1, Suppl. Video 1). 
2. The blind phase. We called this phase blind because it could not be completely 
controlled with the 3D navigation system and the TEE. Once the SL1 sheath was placed in the 
desired position, it was fixed and the dilator was inserted over the wire. To avoid uncontrolled 
contact of the dilator with the SVC tissue, it was inserted into the sheath until marker “2” on 
the dilator. After the wire was withdrawn the dilator was aspirated and flushed with saline.  
The RF-needle was then inserted into the dilator in consideration of special markers. 
The RF needle has a short pin directly after the handle part, from this pin the needle arises. 
The distance from the end of this pin to the dilator orifice should be equal to the length of the 
pin itself (Fig. 2A). The RF needle was then flushed with saline and connected to the cable 
and pressure line. Once this position was reached, the RF-needle together with the dilator was 
fixed and the sheath was slid gently back until a connection (click) with the dilator occurred 
(Fig. 2B). Afterwards, the sheath and the dilator were sliding together backwards for 2–3 mm, 
while the RF needle remained fixed. Once the tip of the RF needle left the dilator, a unipolar 
point appeared on the 3D map (Fig. 2C). The whole assembly of the sheath, dilator and the 
needle were now  slid back until a drop into the fossa ovalis occurred. It should be noted that 
the needle and the sheath position were similar to the standard TSP technique.  
3. Transeptal puncture. Once the RF-needle was pulled back from the SVC and 
dropped into the fossa ovalis, the TEE image showed the “tenting” of the interatrial septum, 
ensuring a correct needle position. After reaching the correct position, RF energy was 
delivered. Specific spontaneous echo contrasting occurred during the energy application on 
the TEE picture. The “tenting” of the IAS disappeared and the needle was inserted into the 
LA. The needle was aspirated and flushed with saline, and a spontaneous contrasting effect 
was seen at this moment in the LA, confirming the correct position of the needle (Fig. 3, 
Suppl. Videos 2, 3). 
A single TSP was used and the ablation catheter was placed beside the multipolar 
mapping catheter once the SL1 sheath was pulled back into the right atrium.  
The mapping of LA was provided with a multipolar catheter (Advisor™ FL Circular 
Mapping Catheter, Sensor Enabled™, Abbott, USA, n = 6; Advisor™ HD Grid Mapping 
Catheter, Sensor Enabled™, Abbott, USA, n = 4). 
At first the anatomy of all pulmonary veins were collected (LSPV-LIPV-RSPV-RIPV) 
followed by a complete geometry of the LA-box. Next the anatomy of the LA-roof was 
completed. The following step was mapping the LAA, the anterior wall and atrial septum. 
Finally, the inferior wall of the LA was mapped. A voltage map was collected simultaneously 
with the anatomical map, which supplies additional information of the LA substrate. 
Pulmonary vein gaps were marked with tag points during mapping as well. During AF a 
complex fragmented atrial electrograms (CFAEs) map was also provided. 
 
Results 
Intravenous infusion of 49.5  27 mL Propofol 1% and 0.043  0,027 mg Fentanyl 
injection was needed for stable sedation. No re-map was needed in this study.  
After safe TSP was done in all cases, an LA anatomical and voltage map was created. 
The re-isolation of pulmonary veins was the initial strategy. In 4 cases, all pulmonary veins 
were isolated. In 6 patients, re-PVI was performed (1 patient — 4 PVs; 3 patients —2 PVs; 2 
patients — 1 PV).  
In 5 cases, linear ablation of the LA for treatment of left atrial macro re-entry 
tachycardia was provided. In 2 patients, focal atrial tachycardia was documented, 1 patient 
underwent cavo tricuspidal isthmus (CTI) ablation and one patient re-CTI ablation. The 
ablation of CFAEs was done in two patients. In 1 case, RA macro re-entry tachycardia was 
treated. Mean procedural time (the time from groin puncture until hemostasis, including 
waiting time) was 107.5  37.1 min. No complications occurred during or after the procedure. 
Mean hospitalization time was 3  0.9 days. All patients remained on anti-arrhythmic therapy 
for 3 months after ablation. After an 8.9  4-month follow-up period, 2 patients had an 
arrhythmia recurrence. The periprocedural characteristics are presented in Table 1.  
 
Discussion 
Non-fluoroscopy technique for treatment of SVT  
As mentioned above, a non-fluoroscopy approach using a 3D navigation system is 
increasingly recognized as a future technology in arrhythmia treatment. The treatment of 
right-sided SVT without fluoroscopy is already a well approved method and is a standard 
technique at many institutions including the one documented [2, 3]. Herein, it is strongly 
recommended to start with right-sided SVT ablation once it has been decided to implement a 
non-fluoroscopy technique in your laboratory. Only after a learning curve is completed, 
consider starting with a non-fluoroscopy TSP [4]. 
 
Non-fluoroscopy mapping and ablation of the LA after TSP  
To investigate the effectiveness and safety of the reconstruction of LA and PVI 
without fluoroscopy, Zhang et al. [5] enrolled 342 patients with paroxysmal AF. After X-ray-
guided TSP, patients were divided in two groups — reconstruction of LA and PVI with and 
without the use of fluoroscopy. The X-ray time of LA reconstruction and PVI was 7.6  1.3 
min in the group with fluoroscopy and the total X-ray exposure dose was more than 6-fold 
higher compared to the group without fluoroscopy. Fluoroscopy time before LA  
reconstruction was similar in both groups (2.8  0.4 and 2.4  0.6 min) [5]. Recently, Raju et 
al. [6] published the experience using the near zero fluoroscopy ablation technique for 
complex LA ablations using the electro-anatomic mapping system and TEE. The authors 
showed that the reduction of fluoroscopy time and radiation dose was statistically relevant in 
the non-fluoroscopy group compared with the control group. Moreover, in the majority of 
patients with patent foramen ovale (36% in this study), zero fluoroscopy was possible [6].  
The right-sided and left-sided atrial reconstruction without fluoroscopy using a 3D-
navigation system seems to be an effective and safe method. The next most important 
question is; if the transseptal punction is also safe and effective when using a non-fluoroscopy 
technique. By re-PVI, the incidence of the iatrogenic atrial septal defect after 12–36 months 
after PVI varies 20–37% using cryoballoon and 9–19% using the RFA technique. That means 
that up to one-third of re-PVI procedures after initial cryoballoon therapy (which have been 
increasing over the last few years) can be performed without using TSP [7]. 
 
TSP without fluoroscopy  
Ferguson et al. [8] published a series documenting 21 patients with AF where 19 
patients underwent TSP without fluoroscopy, using intra-cardiac echocardiography (ICE), and 
an electro-anatomic mapping system. For double TSP, the authors used a conventional 
transseptal needle which was facilitated by electrocautery. This technique showed good 
results and was deemed safe in all cases [8]. Bulava et al. [9] demonstrated the result of 
ablation on eighty patients with paroxysmal AF randomized 1:1 ratio to undergo PVI with and 
without fluoroscopy. TSP in the group without fluoroscopy was performed by ICE guiding 
and using the CARTO 3 system. The total procedure and ablation time were comparable in 
both groups. All but 1 patient received zero fluoroscopy treatment in the non-fluoroscopy 
group. No procedure-related complications occurred in this study [9]. O’Brien et al. [10] 
demonstrated that after an adequate learning curve fluoroscopy-free TSP and ablation of 
complex left-sided atrial arrhythmias were safe and feasible in most patients. More recently, 
Sawhney et al. [11] published a stepwise approach to the non-fluoroscopy TSP technique in 
32 patients using an Endrys Coaxial needle, which was visualized on the CARTO system 
without the use of TEE or ICE. The TSP was performed safely and effectively using the non-
fluoroscopic technique in a select group of patients [11]. 
 
The RF transseptal needle 
Recently, a RF needle was developed. The first data showed that the use of an RF 
needle for TSP was associated with a lower total procedural time and lower risk of acute 
cerebral embolism during the catheter ablation of AF [12]. In this study Tokuda et al. [12] 
enrolled 383 consecutive patients who underwent catheter ablation for AF that required TSP 
using mechanical or RF transseptal needles. All patients had a cerebral magnetic resonance 
imaging performed 1 or 2 days after the procedure. Total procedure time was significantly 
shorter in the RF group than the non-RF group (167 ± 50 vs. 181 ± 52 min, p = 0.01). The 
incidence of ACE was lower in the RF group than the non-RF group (19 vs. 32%, p = 0.02). 
This can be attributed to some advantages of using the RF-needle: It enables crossing the thin 
aneurismal septum while reducing excessive tenting; can cross the fibrotic septum while 
reducing mechanical force; can cross the septum at a precise location; and the rounded 
atraumatic tip reduces the risk of skiving and embolism. As mentioned above, it also reduces 
transseptal procedure and fluoroscopy time vs. mechanical needle. Is easy to visualize on 
fluoroscopy (as well as on TEE) because of the radiopaque marker; and is easy to trace the tip 
of the needle on the 3D mapping system [13–16].  
In the present study, the RF needle for TSP was used without the use of fluoroscopy.  
A single TSP was used and the ablation catheter was placed beside the multipolar mapping 
catheter.  Double TSP can also be performed by repeating the above-described steps.  
According to available research, this is the first series of patients where the transseptal 
punction was performed with RF-needle using the non-fluoroscopy technique. With regard to 
the advantages described above, based on  prior experience, it can be said that the RF needle 
is well suited for the non-fluoroscopy technique.  Using this technique, it is possible to:  
— Trace the RF-needle tip in the 3D navigation system before, during and after TSP 
(minimizing the blind phase); 
— To see the highly echogenic tip of the RF-needle in the TEE image; 
— To monitor the pressure shift during the TSP; 
— To see the spontaneous contrast effect in the LA while injecting the saline in the RF-
needle after TSP. 
This method is not only effective, but also safe. The safety concern in the present study 
was based on the following points: 
— Always sliding the sheath, introducer and the needle backwards during the blind 
phase;  
— Live TEE imaging during the TSP; 
— Adequate sedation of the patient, which allows a stable map; the soft tip of the SL1 
sheath provides better safety. 
 
Limitations of the study 
The non-fluoroscopy group of patients was not compared with conventional groups. 
Limited number of patients. 
 
Conclusions 
Non-fluoroscopy TSP using an RF needle, traced with the 3D navigation system and 
TEE is a safe and effective technique. Further investigation of this method is needed. 
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Table 1. Periprocedural characteristics 
Case AF form PVI  Re-PVI LAMRT (linear ablation) CFAEs RAMRT CTI 
1 Persistent CRYO RSPV, LIPV – – – – 
2 Persistent CRYO LSPV, RIPV – – CT Re-CTI 
3 Persistent CRYO – Left isthmus, LA anterior IAS, LA inferior – – 
4 Paroxysmal CRYO RSPV, RIPV IAS – – – 
5 Persistent CRYO/RF – Left isthmus – – – 
6 Persistent CRYO/RF RIPV Left isthmus, IAS IAS, LA inferior, 
LA posterior 
– – 
7 Persistent CRYO – Left isthmus, LA–Roof, 
inferior box–line 
– – – 
8 Persistent RF All PVs – – – – 
9 Persistent CRYO RSPV – – – – 
10 Paroxysmal CRYO – – – – CTI 
CFAE — complex fragmented atrial electrograms; CT — crista terminalis; CTI — cavo tricuspidal isthmus; IAS 
— inter atrial septum; LA — left atrium; LAMRT — left atrial macro re-entry tachycardia; LIPV — left inferior 
pulmonary vein; LSPV —  left superior pulmonary vein; PVI — pulmonary vein isolation; RAMRT — right 
atrial macro re-entry tachycardia; RF — radiofrequency; RIPV — right inferior pulmonary vein; RSPV — right 
superior pulmonary vein 
 
 
 
Figure 1. An anatomical map of the right atrium, inferior and superior vena cava and 
coronary sinus. The bundle of His is marked with a yellow point. The multipolar diagnostic 
catheter placed in the coronary sinus (blue color). On the left side, the right anterior oblique 
(RAO) projection is presented. On the right side, the left anterior oblique (LAO) projection is 
presented; A. The ablation catheter is placed in the superior vena cava; B. The SL1 sheath 
slides over the catheter (which is stabilized in this position) until its tip comes into contact 
with the proximal poles of the ablation catheter resulting in an impedance change and shifting 
the part of the catheter shape out of the map; C. Once the sheath slides a bit more distally, the 
distal poles of the ablation catheter come into contact with the sheath and the whole catheter 
shape jumps out from the map. This is a sign that the tip of the SL1 sheath is now in the place 
of the distal part of the catheter (Position A).  
 
 
Figure 2. The steps of the “blind phase”; A. At the start position, the dilator is inserted into 
the sheath until the marker “2”. The radiofrequency (RF) needle is inserted into the dilator 
until the distance between the end of the pin on the needle and the dilator orifice is equal to 
the length of the pin itself. Now the needle and dilator are fixed and the sheath slides back 
over the dilator; B. The connection of the sheath with the dilator (a specific “click”) confirms 
the connection. Now the dilator and the sheath are sliding back and the needle is still fixed; C. 
The final position of the sheath dilator and the needle assembly before pulling back. The first 
two steps (A and B) cannot be traced using the three-dimensional (3D) navigation system. 
The right side (C) shows the 3D anatomical map of the right atrium, superior vena cava and 
coronary sinus in the left anterior oblique projection. The green point depicts the unipolar 
signal of the RF-needle once it appears out from the dilator. In the left upper corner of each 
picture, the corresponding picture of the distal part of the sheath is shown. Please note the 
gummy tip of the SL1 sheath, which offers additional safety.  
 
Figure 3. Left side three-dimensional (3D) anatomical map of the anatomical structures in the 
right anterior oblique and left anterior oblique projections; right atrium (grey), superior vena 
cava (SVC) (yellow), inferior vena cava (purple), coronary sinus (red) and right ventricle 
(green). The blue point depicts the ideal location for transseptal puncture, which was marked 
with the radiofrequency (RF)-catheter before. On the right side, TEE pictures of the IAS in 
short and bicaval planes; A. The RF-needle (the green point) moves from the SVC towards 
the interatrial septal (IAS). This step cannot be traced using transesophageal 
echocardiography (TEE); B. The tip of the RF-needle reached the desired place. The TEE 
picture showing the “tenting” of the IAS confirms a safe position of the needle; C. The tip of 
the needle is in the left atrium, out of the right atrium map. TEE pictures show specific 
spontaneous echo contrasting during energy application. Note, the “tenting” disappears after 
RF delivery.  



